Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children
Launched by SEATTLE CHILDREN'S HOSPITAL · Feb 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special online program can help parents with Irritable Bowel Syndrome (IBS) teach their young children healthy habits and coping skills. The program is called REACH, and it aims to find out which type of online support is more effective for parents: one that focuses on general child health and safety or another that promotes wellness behaviors specifically. Parents will be asked to fill out online surveys and use one of the two websites chosen randomly, like flipping a coin.
To participate, parents need to be at least 18 years old and have a diagnosis of IBS or similar abdominal pain. They should also be the primary caregiver for a child between the ages of 4 and 7 who lives with them at least half of the time. Participants will need regular access to the internet and must be able to read and understand English. This study is open to all genders and is currently recruiting participants. It's a great opportunity for parents looking for support in raising resilient children while managing their own health.
Gender
ALL
Eligibility criteria
- Inclusion criteria for parents and their children (including biological/step-parents or legal guardians):
- • Parent/caregiver at least 18 years old
- • Parent diagnosed with IBS or idiopathic abdominal pain in the last five years OR
- • Parent meets ROME criteria for IBS (abdominal pain at least weekly; pain related to defecation, change in stool frequency, and change in stool form at least 30% of the time)
- • Is the parent primarily responsible for caring for the child on a day-to-day basis
- • Child is 4 to 7 years old at the time of screening. If multiple children are present in the family, the parent will be asked to select one child for study participation.
- • Child must currently live at least half of the time with the parent involved in intervention.
- • Parent and child must reside in the U.S.
- Exclusion criteria for parents and their children:
- • Not able to read/speak/understand English.
- • Child has a developmental disability that requires full-time special education
- • Child has chronic abdominal pain (pain most/every day for more than 3 months)
- • Child has a current doctor's diagnosis of a painful\* gastrointestinal disorder like functional constipation, lactose/fructose/gluten intolerance, celiac disease, Inflammatory Bowel Disorder, etc. (\*does not include nonpainful disorders like GERD)
- • Child has another severe chronic disease such as juvenile arthritis, cancer, or other severe condition(s) requiring chronic medical treatment.
- • Does not have regular access to the Internet on a desktop, tablet, phone, or laptop computer
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials